Jayasree Iyer – CEO, Access to Medicine Foundation
Speaking to PharmaBoardroom in the context of our upcoming InFocus special report on HIV, Access to Medicine Foundation CEO Jayasree Iyer looks back on pharma’s successes and failures in access…
Address: Goirleseweg 15, 5026 PB Tilburg, P.O. Box 3240, 5003 DE Tilburg, The Netherlands
Tel: +31 (0)88 8311120
The mission of the N.V. Noord-Brabant Development Agency (BOM) is to create, improve, maintain and develop the industrial structure in Noord-Brabant by offering a range of professional services. The BOM was established in 1983 and is funded and financed by the Dutch State and the Province of Noord-Brabant. Noord-Brabant is a region in the south of the Netherlands. The BOM offers four core activities:
The BOM Foreign Investment Department assists potential foreign investors in every field required, free of charge. The BOM organizes fact-finding trips, visits potential investors abroad and supports in site-selection and negotiations with national and local authorities.
The BOM Venture Capital Department finances innovative and financially healthy companies by providing equity capital and subordinated loans of up to 1,8 million Euros.
The BOM New Business Development department supports R&D programs and initiates and stimulates innovative industrial projects. Moreover, the BOM offers access to its network with the local, national and European business communities as well as with universities, research centers and financial institutions. Furthermore, the BOM provides financing for the above-mentioned projects as well as privately owned companies which need equity financing.
BOM Business parks focus on the development of the regions industrial estates. BOM is responsible for redeveloping 1,295 hectares which equate to around 25% of the region’s current industrial estates.
BOM Foreign Investments
The BOM’s team of business professionals and engineers provide a wide range of services to help foreign companies reach their European customers via the Netherlands and the province of Brabant, gaining the best return on investment.
BOM Foreign Investments aims to strengthen the industrial and economic structure of the network and its area. These services include a complete foreign investment promotion and acquisition program. BOM Foreign Investments facilitates foreign companies’ direct investment in Brabant; whether developing a first European presence or optimizing existing European operations, companies can obtain information, strategic perspective and practical assistance from BOM’s business professionals. BOM’s services are confidential and free of charge:
Providing all relevant information concerning the national and regional business climates, including labor, taxes, industrial sites, office locations, residence and work permits, international schools and quality of life.
Personal guidance through the complete site selection process; organizing fact finding trips and ensuring that all available real estate options (new, existing, buy, rent) are considered.
Introducing companies to a large variety of relevant contacts: national or regional, government or industry, OEM or supplier, public or private consultants, education and training institutes, real estate and development agencies.
BOM has helped hundreds of foreign companies initiate or expand operations in Brabant. We provide a high quality service to you o
The BOM’s team of business professionals and engineers provide a wide range of services to help foreign companies reach their European customers via the Netherlands and the province of Brabant, gaining the best return on investment.BOM Foreign Investments aims to strengthen the industrial and economic structure of the network and its area. BOM’s services are confidential and free of charge and include:
Providing all relevant information concerning the national and regional business climates, including labor, taxes, industrial sites, office locations, residence and work permits, international schools and quality of life.
Personal guidance through the complete site selection process; organizing fact finding trips and ensuring that all available real estate options (new, existing, buy, rent) are considered.
Introducing companies to a large variety of relevant contacts: national or regional, government or industry, OEM or supplier, public or private consultants, education and training institutes, real estate and development agencies.
BOM has helped hundreds of foreign companies initiate or expand operations in Brabant. We provide a high quality service to you or any partner interested in establishing activities in Noord-Brabant. Please feel free to contact us.
Speaking to PharmaBoardroom in the context of our upcoming InFocus special report on HIV, Access to Medicine Foundation CEO Jayasree Iyer looks back on pharma’s successes and failures in access…
Marijn Verhoef, Director of Operations and Research at the Access to Medicine Foundation examines the interconnected challenges of drug shortages and antimicrobial resistance. Verhoef urges decisive and urgent action from…
The EMA’s Peter Arlett looks back on two years of the Accelerating Clinical Trials in the European Union (ACT EU) initiative which aims to improve the environment for clinical trials…
New methodology for the 2024 Access to Medicine Index promises a stronger attempt to quantify whether drugs, vaccines, and diagnostics are actually making it all the way to patients in…
Claudia Martínez, generic & biosimilar medicines programme manager at the Access to Medicine Foundation, draws from a recent AMF report to outline what more generics companies can be doing to…
As part of a wide-ranging conversation with PharmaBoardroom published earlier this month, European Medicines Agency (EMA) Executive Director Emer Cooke laid out four of the Agency’s core focus areas for…
In conversation at DIA Europe 2023 in Basel, European Medicines Agency Executive Director Emer Cooke looks back at the lessons EMA has taken from the COVID-19 pandemic response, outlines the…
The Access to Medicine Index, a biennial report that gauges the efforts of the world’s largest pharma companies to expand access in low- and middle-income countries (LMICs), found in this…
The latest news from the Dutch pharma, biotech and healthcare industries, including the bullish comments of Argenx CEO Tim Van Hauwermeiren following the successful launch of its Vyvgart product; cancer…
The European Medicines Agency (EMA), the EU body responsible for the evaluation of medicinal products for use within the European Union, concluded a vote on Monday evening in Brussels following…
Leo de Haan of Aurobindo discusses how to maintain a profitable business in times of rock-bottom generics prices in the Netherlands, the resulting second pillar of specialty products for the…
Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by Schering Plough, the Netherlands nevertheless still sits in fourth position on the 2015…
See our Cookie Privacy Policy Here